Long-term results of endoscopic tissue removal for upper stomach and food-pipe tumours
Follows adults treated for upper digestive tract tumours with endoscopic tissue removal over time.
Plain-language title generated from the registry record
Registry title: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Key facts
- Where
- Sydney, AustraliaSee the site
Where in Australia
- Westmead HospitalSydney, AustraliaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Western Sydney Local Health District
- Trial code
- NCT05804331
- Record updated
- 27 March 2025
- Original description
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesionsRead full original descriptionShow less
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Inclusion: UGI neoplastic lesions > 10mm; Lesions for ESD limited to the mucosal and/or submucosal layer OR; Lesions for EFTR limited to the muscularis propria layer OR; Lesions for STER limited to the submucosal and/or muscularis propria layer; Aged 18 years or older.
Exclusion: Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally; Age less than 18; Unable to give informed consent; Pregnant or lactating patients.